China Aims To Reform Hospital Drug, Test Overuse To Increase Revenues
This article was originally published in PharmAsia News
China, in a bid to reduce hospital costs, is proposing another five-year medical-coverage plan, part of which would address large public hospitals relying on drug sales to increase revenues.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.